Skip to content

Adaptive Biotechnologies

US · ADPT #2184 by market cap Listed 2019
27.93 -0.12 -0.43%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 8 analysts

Buy
Avg price target 33.43 +19.7%
Price target rangecurrent 27.93
Low27.00
Avg33.43
High35.00
Buy 88% Hold 13% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-10 Piper Sandler -- Buy 35.00
2026-11-10 Guggenheim -- Buy 34.00
2026-11-09 J.P. Morgan -- Buy 35.00
2026-11-05 TD Cowen -- Buy 34.00
2026-11-05 Piper Sandler -- Buy 27.50
2026-11-05 BTIG -- Buy 34.00
2026-10-14 J.P. Morgan -- Buy 30.00
2026-10-13 TD Cowen -- Buy 32.00
2026-10-13 Morgan Stanley -- Hold 27.00
2026-10-09 Morgan Stanley -- Hold 27.00
2026-10-01 Guggenheim -- Buy 32.00
2026-09-29 Goldman Sachs -- Buy 35.00
2026-09-22 BTIG -- Buy 34.00
2026-09-21 BTIG -- Buy 34.00
2026-09-17 Craig-Hallum -- Buy --
2026-08-24 Piper Sandler -- Buy 27.50
2026-08-04 Piper Sandler -- Buy 27.50
2026-07-30 TD Cowen -- Buy 28.00
2026-07-30 William Blair -- Buy --
2026-07-30 BTIG -- Buy 25.00
2026-07-30 J.P. Morgan -- Buy 27.00
2026-07-29 TD Cowen -- Buy 28.00
2026-07-29 Guggenheim -- Buy 25.00
2026-07-22 BTIG -- Buy 24.00
2026-07-15 TD Cowen -- Buy 25.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 After close ±13.83% +0.45% (in line)
2026/Q2 2026-07-29 After close ±17.85% +7.18% (in line)
2026/Q1 2026-05-05 After close ±22.59% +4.72% (in line)
2025/Q4 2026-02-05 After close ±16.09% -4.25% (in line)
2025/Q3 2025-11-05 After close ±19.37% -11.54% (in line)
2025/Q2 2025-08-05 After close ±32.38% +5.79% (in line)
2025/Q1 2025-05-01 After close ±21.74% +33.70% (beat)
2024/Q4 2025-02-11 After close ±21.71% -3.21% (in line)
2024/Q3 2024-11-07 After close ±24.96% +3.37% (in line)
2024/Q2 2024-08-01 After close ±20.90% -3.37% (in line)
2024/Q1 2024-05-07 After close ±28.30% +2.25% (in line)
2023/Q4 2024-02-14 After close ±37.34% +0.51% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.

Adaptive Biotechnologies discussion 0 comments

Add a comment